Benzodiazepine and Z-Drug Use in Switzerland: Prevalence, Prescription Patterns and Association with Adverse Healthcare Outcomes
Salome Landolt,1 Thomas Rosemann,1 Eva Blozik,1,2 Beat Brüngger,2 Carola A Huber1,2 1Institute of Primary Care, University of Zürich, University Hospital Zürich, Zürich, Switzerland; 2Department of Health Sciences, Helsana Insurance Group, Zürich, Switzer...
Guardado en:
Autores principales: | Landolt S, Rosemann T, Blozik E, Brüngger B, Huber CA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1d777b9291564650b5ba724170a3af5f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Sunshine hours and utilization of benzodiazepines
por: Marković Srđan Z., et al.
Publicado: (2021) -
Adherence to levothyroxine prescription in patients with hypothyroidism
por: Machado-Alba,Jorge E., et al.
Publicado: (2020) -
Benzodiazepine and Z-drug consumption in a national social security organization in Argentina: rational or excessive use?
por: Gustavo Marin, et al.
Publicado: (2021) -
Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment
por: Kawamata Y, et al.
Publicado: (2021) -
Epidemiology and costs of multiple sclerosis in Switzerland: an analysis of health-care claims data, 2011–2015
por: Blozik E, et al.
Publicado: (2017)